We came across a bullish thesis on Anheuser-Busch InBev SA/NV (NASDAQ:BUD) on ValueInvestorsClub by investor8888. In this article, we will summarize the bulls’ thesis on BUD. The company’s ...

NextDecade Stock Performance Shares of NASDAQ NEXT opened at $6.86 on Friday. The company has a debt-to-equity ratio of 3.17, a current ratio of 0.49 and a quick ratio of 0.49. The firm has a ...

Pictet Asset Management Holding SA acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the fourth quarter, Holdings Channel reports.The institutional investor acquired 5,905 ...

When forex trading, staying informed with accurate and timely news is essential for making informed decisions. For South African traders, accessing reliable forex news sources can majorly improve ...

It creates uncertainty and the market hates that! Notably, Moderna’s (NASDAQ:MRNA) 9% haircut on Monday spoke volumes. The company has two FDA-approved vaccines and is awaiting word on a few more.

Palantir (NASDAQ:PLTR) shares have been volatile in recent weeks amid heightened concerns about tech stock valuations, increased tariffs and decreased government spending. Shares of the software ...

We see price action on the NASDAQ at support at levels not seen since last September. Yesterday’s low represents a 15% drop from the highs, but this is no ordinary correction. Yes, the 15% drop ...

Innate Pharma S.A. (NASDAQ:IPHA) Q4 2024 Earnings Call Transcript ... impact of lacutamab on patient well-being. There was also a poster presentation of translational data from the TELLOMAK ...

ADC Therapeutics SA (ADCT) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $1.03 per share a year ago.

ADC THERAPEUTICS SA -REDH ($ADCT) posted quarterly earnings results on Thursday, March 27th. The company reported earnings of -$0.29 per share, beating estimates of ...